| abstract |
The invention relates to a soft capsule for treating nerve diseases. The soft capsule comprises a liquid medicine and a soft capsule casing for sealing the liquid medicine, wherein the liquid medicine contains active ingredients. The medicine composition of the soft capsule is the only medicine which achieves double improvements on brain metabolism and psychiatric symptoms and has no direct competitor at present; and the soft capsule is a brain metabolism improver and cranial nerve cell protective agent, can prevent mitochondrial diseases, inhibit platelet aggregation and improve microcirculation effectively, has an effective antioxidation function, and is also a preferred medicine for treating FRDA (Friedreich ataxia). The successful development of the soft capsule can provide enormous economic and social benefits for the pharmacy industry. |